Liver clinical trials

Fluorescence-guided surgery for liver cancer

This trial tests a new way to remove liver cancer during surgery. A special dye called ICG is injected into the artery leading to the liver, which makes the tumor glow under a special camera, helping the surgeon remove just the right area. This study checks if this technique is both safe and effective for people with a common type of liver cancer (hepatocellular carcinoma).

Personalized TARE treatment planning for liver cancer

This trial is testing a new computer tool that uses your own scans to plan TARE treatment for liver cancer. The goal is to make the treatment more personalized and effective.

Using sound waves to measure liver fat

This study tests a new method that uses sound waves to measure fat in your liver. It could help doctors check liver health without a biopsy.

Detecting liver scarring in chronic liver disease

This trial looks for better ways to detect liver scarring (fibrosis) in people with long-term liver disease. It may help find problems earlier.

Noninvasive scan to check liver fat and scarring

This study tests a noninvasive FibroScan machine to help measure liver fat and possible liver scarring using information collected in a database. It may help researchers improve how liver problems like fat buildup and scarring are identified and tracked.

Microarray testing to guide care after liver transplant

This study looks at how special lab tests from tiny tissue samples (microarrays) could help guide diagnosis and treatment in people who receive a liver transplant. It may help doctors better understand what’s going on and choose care more accurately.

Study of drug-related liver injury in China

This study follows people who developed liver injury from a medicine (not from other causes). It aims to better describe different types and severities of drug-related liver injury and may help improve how clinicians recognize and manage it.

Predicting Liver Failure in People with Cirrhosis

This study follows people with liver cirrhosis—a condition where the liver is scarred—to see who gets worse or develops sudden liver failure. The goal is to find early warning signs so doctors can help prevent serious problems.

Tesamorelin for reducing liver fat in fatty liver disease

This trial tests if tesamorelin, a daily injection, can reduce liver fat in adults with fatty liver disease. It may help people whose liver has fat but is not yet scarred into cirrhosis.

Testing a new liver scanning device for fatty liver disease

This study tests a new device called LiverScope® that scans your liver to detect fatty liver disease (MASLD). The scan uses special imaging technology and may help doctors diagnose liver disease more quickly and accurately.

Liver Cancer Patient Database Study

This study builds a database of information from liver cancer patients treated at Tongji Hospital. Researchers will collect your medical records and treatment information to better understand liver cancer diagnosis and care over time.

VitaSmart HOPE System liver transplant registry

This study follows people who receive a liver transplant using a special machine called the VitaSmart HOPE System, which keeps the donated liver healthy before transplant. The study tracks how well these livers work after transplant.

ABO-mismatched living donor liver transplant study

This study looks at the results of liver transplants from living donors with a different blood type than the recipient. It aims to understand how well patients do after this type of transplant.

Fatty liver risk screening in the emergency department

This study looks at fatty liver findings on emergency department scans. If you have fatty liver and were sent home from the ED, the study may help connect you to follow-up care and avoid future liver problems.

Using liver stiffness to predict varices in advanced liver cancer

This trial uses a simple ultrasound test (measuring liver and spleen stiffness) to predict if a patient with cirrhosis and advanced liver cancer has enlarged veins in the esophagus. The goal is to avoid unnecessary invasive procedures like endoscopy.

Liver imaging study for children with obesity

This study uses MRI scans to look at the livers of children with obesity, to find early signs of liver problems. It may help doctors understand how to protect the liver in children.

Study BK virus after combined liver and kidney transplant

This study looks at how often BK virus shows up in people after a combined liver-kidney transplant. It may help the transplant team better predict and manage this virus after surgery.

Study of liver cancer patients getting proton beam therapy

This study follows people with liver cancer who are scheduled to receive proton beam therapy. It looks at how patients do after treatment and what to expect going forward.

Training program before and after liver transplant

This trial studies a structured exercise and training program before and after liver transplantation to help people recover better. You may be able to benefit if you’re getting an elective liver transplant and can safely participate in the training plan.

Second-Generation Laryngeal Mask Airway vs Endotracheal Intubation in Adult Liver Transplantation

Testing an experimental drug for liver cirrhosis caused by MASH

This study tests an investigational medicine (BI 3802876) in people with early-stage liver cirrhosis due to MASH. The goal is to see if it is well tolerated and potentially helpful.

MRI study of blood-vessel and tissue signs in child liver disease

This trial uses MRI scans to look for “biomarkers,” which are measurable signs in the liver, to better understand autoimmune liver diseases in children and teens. It may help doctors track disease and improve care by finding imaging patterns linked to illness.

N-acetylcysteine for liver failure not caused by acetaminophen

This trial tests whether the drug N-acetylcysteine (NAC) can help people with sudden liver failure that is not caused by acetaminophen (like Tylenol). If you qualify, you may receive NAC, which might help your liver recover.

Blood thinner pills in people with mild-to-moderate cirrhosis

This early study tests whether the blood thinner pills rivaroxaban and apixaban can be used safely in people with liver cirrhosis that is not too severe. It may help doctors understand the safest way to prevent or treat blood clots in this group.